Articles/ Views and analysis Executive perspectives: Robert Hugin Catherine 0 Comment As pharmaphorum continues to connect with those senior executives who are shaping the future of the pharmaceutical industry, Share X Executive perspectives: Robert Hugin https://pharmaphorum.com/views-and-analysis/executive-perspectives-robert-hugin/
Articles/ Views and analysis A history of Abbott and AbbVie Catherine 0 Comment This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – Share X A history of Abbott and AbbVie https://pharmaphorum.com/views-and-analysis/a-history-of-abbott-and-abbvie/
Articles/ Views and analysis Pharma news highlights: Chinese bribery scandal, possible pharma merger Catherine 0 Comment Ed Silverman shares his thoughts on some of the latest pharma news stories from the last four weeks, Share X Pharma news highlights: Chinese bribery scandal, possible pharma merger https://pharmaphorum.com/views-and-analysis/pharma-news-highlights-chinese-bribery-scandal-possible-pharma-merger-2/
Articles/ Views and analysis Building momentum to end AIDS, TB and malaria Catherine 0 Comment In Eli Lilly and Company’s latest article, Evan Lee discusses how the pharma industry is building momentum in Share X Building momentum to end AIDS, TB and malaria https://pharmaphorum.com/views-and-analysis/building-momentum-to-end-aids-tb-and-malaria/
Articles/ Views and analysis Why is rare disease funding rare? Catherine 0 Comment Oliver Timmis explores the problems associated with securing funding for rare disease research and questions why more funding Share X Why is rare disease funding rare? https://pharmaphorum.com/views-and-analysis/why-is-rare-disease-funding-rare/
Articles/ Views and analysis The Global Publication Survey (GPS): update and implications Catherine 0 Comment Tom Grant and Professor Karen Woolley provide us with an update to ISMPP’s Global Publication Survey for medical Share X The Global Publication Survey (GPS): update and implications https://pharmaphorum.com/views-and-analysis/the-global-publication-survey-gps-update-and-implications/
Articles/ Views and analysis Pharmacovigilance and risk management information in centralised applications in the EU Catherine 0 Comment Véronique Basch provides us with an overview of the new European Union pharmacovigilance legislation and how it affects Share X Pharmacovigilance and risk management information in centralised applications in the EU https://pharmaphorum.com/views-and-analysis/pharmacovigilance-and-risk-management-information-in-centralised-applications-in-the-eu/
Articles/ Views and analysis Breakthrough skin cancer surgery: Interview with Dr Piasecki Catherine 0 Comment Skin cancer is the third most common form of cancer – yet it’s still the one that has Share X Breakthrough skin cancer surgery: Interview with Dr Piasecki https://pharmaphorum.com/views-and-analysis/breakthrough-skin-cancer-surgery-interview-with-dr-piasecki/
Articles/ Views and analysis Why digital needs to be brand specific Catherine 0 Comment In this article, Cognite’s Mike Young discusses the importance of having a brand-specific communication strategy in order to Share X Why digital needs to be brand specific https://pharmaphorum.com/views-and-analysis/why-digital-needs-to-be-brand-specific/
